Life Science Partners (LSP) has announced that Dr Jörg Neermann will join its team as partner operating from the Munich office as of 1 January 2007. Dr Neermann arrives from DVC Deutsche Venture Capital where he was a member of the investment team, building the life science portfolio from 1998 onwards, becoming managing partner in January 2002.
Fund complements PAI's existing large-cap strategy with the aim of targeting mid-sized companies across Europe
Fund invests in European digital platforms and marketplaces, targeting pre-seed and seed rounds
Management team is led by Chris Shaw who was appointed as chief executive in September 2017
GP intends to boost the company's expansion internationally, primarily in Asia, the Middle East and the US